Viatris Inc. Common Stock
VTRSViatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Pfizer’s Upjohn unit. The company specializes in developing, manufacturing, and marketing a broad range of pharmaceuticals, including generic, branded, and biosimilar medicines, with a focus on improving access to affordable healthcare worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 15, 2025 | $0.12 | 2025-11-24 | 2025-11-24 |
| September 15, 2025 | $0.12 | 2025-08-22 | 2025-08-22 |
| June 16, 2025 | $0.12 | 2025-05-23 | 2025-05-23 |
| March 18, 2025 | $0.12 | 2025-03-10 | 2025-03-10 |
| December 13, 2024 | $0.12 | 2024-11-22 | 2024-11-22 |
Dividends Summary
- Viatris Inc. Common Stock has issued 19 dividend payments over the past 4 years
- The most recent dividend was paid 22 days ago, on December 15, 2025
- The highest dividend payed out to investors during this period was $0.12 per share
- The average dividend paid during this period was $0.12 per share.
Company News
Several S&P 500 stocks are trading at low forward price-to-earnings ratios, suggesting potential undervaluation and possible investment opportunities, with some stocks showing potential upside of up to 50%.
QSM Asset Management initiated a new $10.31 million position in Occidental Petroleum, acquiring 221,760 shares in Q3 2025, despite the stock's 18.77% decline over the past year.
The global epinephrine market is projected to grow from $2.77 billion in 2024 to $5.74 billion by 2032, driven by increasing cases of severe allergic reactions, technological advancements in auto-injectors, and rising awareness of anaphylaxis risks.
Four stocks in the S&P 500 have a lower earnings multiple than the 4.9 percentage point gap between the average and median multiple of the index’s components. Click to read more.
Here, we discuss some reasons why investing in Theravance (TBPH) stock now may turn out to be a prudent move.
